ABOUT REZON BIO
Rezon Bio is a science-driven contract development and manufacturing organization (CDMO) specializing in the development and manufacturing of mammalian biologics. Headquartered in Poland, Rezon Bio offers integrated solutions spanning cell line development, commercial drug substance manufacturing, and drug product development. The company operates with state-of-the-art facilities, world-class teams, and a proven track record of regulatory and commercial success. Drawing on a legacy of biosimilars development and global commercialization, Rezon Bio combines experience, digital transparency, and cost-to-value efficiency to help clients move from concept to market with confidence.
INDUSTRY INSIGHTS
-
![GettyImages-2193144544-scientist-cell-culture-in-lab]( "Support A Biosimilar Program From Cell Line Development To Commercial")
Explore end-to-end biosimilar development, combining proven commercial experience, integrated CMC expertise, and seamless GMP manufacturing to accelerate regulatory and commercial success.
-
![pharma-cdmo-GettyImages-2183428951]( "Who Are We And How Do We Differ From Polpharma Biologics?")
Built on decades of pharmaceutical heritage, one company combines proven biologics expertise, world-class facilities, and independent CDMO focus to accelerate global biologics development.
-
![GettyImages-2213035533 microscope, lab]( "Integrated Analytical Development For Biosimilar Comparability Studies")
Discover integrated analytical development for biosimilars, supporting characterization, comparability, validation, and regulatory submissions through co-located expertise and experience.
-
![cmo-biologics-GettyImages-1327624070]( "Can A Single CDMO Manage Both Clinical And Commercial Biologics Supply?")
Learn about integrated clinical-to-commercial biologics manufacturing with scalable GMP capacity, centralized program management, and seamless technology continuity to reduce development risk.
-
![precision safety, workflow optimization, industrial manufacturing-GettyImages-2194643921]( "What Is Rezon Bio's Batch Success Rate And Regulatory Audit Track Record?")
Discover reliable GMP manufacturing with 97% batch success, global regulatory expertise, and unified quality systems supporting clinical through commercial biologics production.
-
![GettyImages-2185301590-microscope-scientist-lab]( "How Efficiently Can We Take An Nbe From Gene To IND?")
Explore streamlined gene-to-IND development for early-stage NBE programs, delivering Phase I readiness through integrated services, rapid scale-up, transparent pricing, and coordinated execution.
-
![The Hidden Challenges Of Biologics Development]( "The Hidden Challenges Of Biologics Development")
Biologics development leaders discuss industry challenges, including innovation pressures, operational complexity, leadership decisions, and maintaining quality and resilience in an evolving landscape.
-
![GettyImages-505766677-team-meeting-collaboration-group-teamwork-discussion]( "Delivering CDMO Excellence, Quality, And Value Through Dedication")
A biologics CDMO combines scientific expertise, flexibility, and partnership to deliver high-quality, cost-efficient development and manufacturing solutions from early stages to commercialization.
CONTACT INFORMATION
Rezon Bio
Trzy Lipy 3, Building A
Gdansk, 80-172
POLAND
Contact: Loukiani Chatzinasiou
SOLUTIONS
-
![clinical-drug-development-GettyImages-1354172647]( "Where Dedication Delivers Value")
Explore a science-driven CDMO offering end-to-end biologics development and manufacturing, with robust quality, scalable capacity, and expertise from clinical to commercial production.
-
![rezon bio integrated biologics]( "Rezon Bio Capabilities Update May 2026: Large Molecule")
Discover how tailored biologics development strategies can improve scalability, reduce tech transfer risk, and create more reliable pathways from early development to commercial supply.
